ArticleJournal of controlled release : official journal of the Controlled Release Society2024

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer.

Jenna N Sjoerdsma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.